DE69927374T2 - Entzündungshemmende pharmazeutische formulierungen - Google Patents

Entzündungshemmende pharmazeutische formulierungen Download PDF

Info

Publication number
DE69927374T2
DE69927374T2 DE69927374T DE69927374T DE69927374T2 DE 69927374 T2 DE69927374 T2 DE 69927374T2 DE 69927374 T DE69927374 T DE 69927374T DE 69927374 T DE69927374 T DE 69927374T DE 69927374 T2 DE69927374 T2 DE 69927374T2
Authority
DE
Germany
Prior art keywords
pharmaceutical formulations
inflammatory pharmaceutical
steroidal anti
inflammatory drug
inflammatory
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69927374T
Other languages
English (en)
Other versions
DE69927374D1 (de
Inventor
Austin John Woolfe
Gordon Mcintyre
Sheth Nitin Vadilal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Norton Healthcare Ltd
Original Assignee
Norton Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norton Healthcare Ltd filed Critical Norton Healthcare Ltd
Publication of DE69927374D1 publication Critical patent/DE69927374D1/de
Application granted granted Critical
Publication of DE69927374T2 publication Critical patent/DE69927374T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69927374T 1998-07-01 1999-06-30 Entzündungshemmende pharmazeutische formulierungen Expired - Lifetime DE69927374T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9814215.1A GB9814215D0 (en) 1998-07-01 1998-07-01 Anti-inflammatory pharmaceutical formulations
PCT/GB1999/001951 WO2000001368A1 (en) 1998-07-01 1999-06-30 Anti-inflammatory pharmaceutical formulations

Publications (2)

Publication Number Publication Date
DE69927374D1 DE69927374D1 (de) 2006-02-02
DE69927374T2 true DE69927374T2 (de) 2006-06-14

Family

ID=10834731

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69927374T Expired - Lifetime DE69927374T2 (de) 1998-07-01 1999-06-30 Entzündungshemmende pharmazeutische formulierungen

Country Status (6)

Country Link
EP (1) EP1091731B1 (de)
AT (1) ATE304844T1 (de)
AU (1) AU4519399A (de)
DE (1) DE69927374T2 (de)
GB (1) GB9814215D0 (de)
WO (1) WO2000001368A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6319519B2 (en) 1998-07-07 2001-11-20 Norton Healthcare Ltd. Anti-inflammatory pharmaceutical formulations
SE9802973D0 (sv) 1998-09-03 1998-09-03 Astra Ab Immediate release tablet
US6387410B1 (en) 1998-09-10 2002-05-14 Norton Healthcare Ltd Anti-inflammatory pharmaceutical formulations
CA2259727A1 (en) * 1999-01-18 2000-07-18 Bernard Charles Sherman A two-layer pharmaceutical tablet comprising an nsaid and misoprostol
US6183779B1 (en) * 1999-03-22 2001-02-06 Pharmascience Inc. Stabilized pharmaceutical composition of a nonsteroidal anti-inflammatory agent and a prostaglandin
WO2001024778A1 (en) * 1999-10-01 2001-04-12 Norton Healthcare Ltd. Anti-inflammatory pharmaceutical formulations
US8206741B2 (en) 2001-06-01 2012-06-26 Pozen Inc. Pharmaceutical compositions for the coordinated delivery of NSAIDs
EP2260837A1 (de) * 2001-06-01 2010-12-15 Pozen, Inc. Pharmazeutische Zusammensetzungen für die koordinierte Abgabe von NSAID
WO2004091579A1 (en) * 2003-04-16 2004-10-28 Pharmacia Corporation Stabilized prostaglandin formulation
WO2006099618A1 (en) * 2005-03-16 2006-09-21 Dr. Reddy's Laboratories Ltd. Delivery system for multiple drugs
EP2167048B1 (de) * 2007-05-30 2016-10-26 Wockhardt Limited Neue tabletten-dosierform
US20090022786A1 (en) * 2007-07-16 2009-01-22 Yung Shin Pharm. Ind. Co., Ltd. Oral pharmaceutical dosage form and manufacturing method thereof
MX2011002515A (es) 2008-09-09 2011-04-07 Astrazeneca Ab Metodo de administracion de una composicion farmaceutica a un paciente que lo necesita.
MX2011013467A (es) 2009-06-25 2012-02-13 Astrazeneca Ab Metodo para tratar un paciente que corre el riesgo de desarollar una ulcera asociada a antiinflamatorio no esteroide (aine).
BR112014016085A8 (pt) 2011-12-28 2017-07-04 Pozen Inc composições aprimoradas e métodos para distribuição de omeprazol mais ácido acetilsalicílico
PE20180605A1 (es) 2015-07-30 2018-04-09 Takeda Pharmaceuticals Co Tableta

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3488418A (en) * 1965-11-18 1970-01-06 Sterling Drug Inc Sustained relief analgesic composition
CA1259924A (en) * 1985-03-25 1989-09-26 Wallace E. Becker Pharmaceutical tableting method
CA2082944C (en) * 1990-05-03 1998-11-24 Rene Antoine Gimet Pharmaceutical compositions
US6077539A (en) * 1996-11-12 2000-06-20 Pozen, Inc. Treatment of migraine headache

Also Published As

Publication number Publication date
DE69927374D1 (de) 2006-02-02
GB9814215D0 (en) 1998-09-02
ATE304844T1 (de) 2005-10-15
EP1091731A1 (de) 2001-04-18
WO2000001368A1 (en) 2000-01-13
EP1091731B1 (de) 2005-09-21
AU4519399A (en) 2000-01-24

Similar Documents

Publication Publication Date Title
DE69927374T2 (de) Entzündungshemmende pharmazeutische formulierungen
ID27504A (id) Formulasi oral baru
DE69832816D1 (de) Orale pharmazeutische dosierungsform mit verlängerter wirkstofffreisetzung
MX9604354A (es) Nueva forma de dosis farmaceutica oral.
EE04003B1 (et) Peroraalne farmatseutiline annusvorm, mis sisaldab prootonpumba inhibiitorit ja NSAID
ATE252892T1 (de) Aus mehreren einzeleinheiten zusammengesetzte arzneimittel mit nicht-steroidalen wirkstoffen (nsaids)
ATE232091T1 (de) Orale pharmazeutische zusammensetzungen mit verzögerter freisetzung von reversiblen protonpumpen-inhibitoren
ATE228009T1 (de) Orale, pharmazeutische darreichungsformen, die einen protonenpumpeninhibitor und ein antacidum oder alginat enthalten
RU94032150A (ru) Лекарственное средство с замедленным высвобождением активно-действующего вещества
DE69805001T2 (de) Osmotische darreichungsform mit zwei mantelschichten
AR035500A1 (es) Uso de clorpromazina y pentamidina para la fabricacion de medicamentos, composicion farmaceutica y paquete farmaceutico que comprenden clorpromazina y pentamidina.
ATE213629T1 (de) Milnacipranhaltige darreichungsform mit verzögerter wirkstoffabgabe
BR0014383A (pt) Composições de liberação controlada compreendendo nimesulida
AR012376A1 (es) Formulacion de gel para la aplicacion topica
DK1112060T3 (da) Doseringsform anvendende flydende formulering
RS50298B (sr) Direktno kompresibilna matrica za kontrolisano oslobađanje pojedinačnih dnevnih doza klaritromicina
DE60102590D1 (de) Darreichungsformen zur behandlung von oralen mykosen
NO20012351L (no) Farmasoytisk sammensetning for modifisert frigjoring av insulinsensibiliserende middel
DE69710423D1 (de) Orale pharmazeutische Zubereitung mit antipyretischer, analgetischer und entzündungshemmender Wirkung.
AR034435A1 (es) Agentes terapeuticos.
ATE158172T1 (de) Pulverförmige pharmazeutische zusammensetzung
DE69914472D1 (de) Levosimendanhaltige oral anzuwendende arzneimittel mit gesteuerter wirkstoffverabreichung
DE69907481D1 (de) Entzündungshemmende pharmazeutische formulierungen
EP0761209A3 (de) Ranitidinformulierungen mit gesteuerter Freisetzung
DE19681529D2 (de) Pharmazeutische Darreichungsform

Legal Events

Date Code Title Description
8364 No opposition during term of opposition